Today: 21 May 2026
IonQ stock ends lower as quantum names cool into the New Year — what’s next for IONQ
1 January 2026
2 mins read

IonQ stock ends lower as quantum names cool into the New Year — what’s next for IONQ

NEW YORK, December 31, 2025, 20:15 ET — Market closed

  • IonQ shares closed down 0.9% at $44.87.
  • IonQ said it finalized a South Korea delivery agreement for its Tempo 100 quantum system.
  • U.S. markets are closed Jan. 1 for New Year’s Day and reopen Jan. 2.

IonQ Inc shares fell 0.9% to $44.87 at Wednesday’s close, after hitting a session low of $44.68 and a high of $46.42. Quantum-computing peers Rigetti Computing, D-Wave Quantum and Quantum Computing Inc also ended lower, and about 11.4 million IonQ shares changed hands.

The group has traded like a high-beta corner of tech, where sentiment shifts can move prices quickly even without major earnings catalysts. For many investors, customer wins and system-delivery milestones remain the clearest near-term signals of demand.

IonQ’s latest headline was a South Korea delivery agreement as the company pushes deeper into installed systems. In a small, early-stage market, that kind of announcement can matter as much for credibility as for near-term revenue.

IonQ said on Monday it finalized an agreement to deliver a 100-qubit Tempo 100 system to South Korea’s Korea Institute of Science and Technology Information (KISTI). “This is a defining moment for both IonQ and South Korea,” Chief Executive Niccolo de Masi said in a statement. A qubit is the basic unit of quantum information, and IonQ did not disclose the contract’s financial terms. IonQ Investors

The company said the system will be integrated with KISTI-6 (“HANGANG”), the country’s largest high-performance computing cluster — the kind of conventional supercomputer used for heavy scientific computing — in an on-site hybrid setup that links quantum and classical machines.

For investors, the next questions are timing and how quickly a delivered system turns into recurring usage and follow-on orders. Without pricing and delivery detail, traders often wait for later disclosures or management commentary.

IonQ’s shares can also move in sympathy with the rest of the quantum-computing group, where momentum has tended to spill across names. That dynamic was visible again on Wednesday as the sector drifted lower into the holiday break.

Before the next session, U.S. stock markets will be closed on Thursday for New Year’s Day and reopen on Friday, January 2, according to the New York Stock Exchange holiday calendar.

Friday’s early economic calendar includes S&P Global’s final U.S. manufacturing PMI for December at 9:45 a.m. ET, a survey of purchasing managers that can shift rate and growth expectations.

The Institute for Supply Management is scheduled to publish its December manufacturing PMI on Monday, January 5, at 10:00 a.m. ET; readings below 50 indicate contraction.

On the company front, IonQ has not announced a date for its next earnings report; MarketBeat’s calendar lists an estimated Feb. 25 release. Investors will look for any update on system-delivery timelines and demand into 2026.

After the holiday, traders will watch whether IonQ can hold above Wednesday’s low and push back toward the session highs, with liquidity typically thinner around the turn of the year.

IonQ, based in College Park, Maryland, sells access to its quantum computers through major cloud platforms, including services run by Amazon, Microsoft and Google, according to a Reuters company profile. It is competing with quantum hardware developers such as Rigetti and D-Wave as customers test early commercial use cases.

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop